Clinical Research
Filter News
Found 103,338 articles
-
Researchers at Massachusetts General Hospital in Boston published results from a long-term clinical trial of a tuberculosis vaccine in type 1 diabetes patients that in a long-term follow-up appears to have cured the disease.
-
The Future of Bioprinting is Here: Poietis and Prometheus Team Up To Develop 3D Printing for Bones
6/21/2018
Poietis along with Prometheus, a division of Skeletal Tissue Engineering at Leuven, Belgium, announced they had entered into a two-year Collaborative Research Agreement to develop high-precision 3D Bioprinting. -
A new report highlights some concerns about the long-term commercial viability of game-changing gene therapies that can radically transform the lives of patients.
-
New Acucela Data on the Effect of Emixustat Hydrochloride on Retinal Thickness in Diabetic Retinopathy
6/21/2018
Acucela Inc., announced today new data on the effect of emixustat hydrochloride on retinal thickness in diabetic retinopathy (DR).
-
MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer
6/21/2018
Data presented at the AACR Cancer Dormancy and Residual Disease meeting support a novel therapeutic approach to combating the spread of aggressive cancer.
-
Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase
6/21/2018
Appili Therapeutics Inc. announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase.
-
Alnylam to Host Fifth Annual “RNAi Roundtable” Webcast Series
6/21/2018
Alnylam Pharmaceuticals, Inc. announced today that it plans to host its 5th annual series of “RNAi Roundtable” webcasts this summer.
-
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
6/21/2018
Clinical studies with aldoxorubicin demonstrated increased progression-free survival and tumor response with low cardiotoxicity
-
LA BioMed’s Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant
6/21/2018
NIH funded research led by Dr. Rie Sakai-Bizmark has potential to save the lives of hundreds of newborn babies annually.
-
Sarepta Therapeutics shares rocketed by as much as 80 percent yesterday after the company released interim data on its experimental gene therapy AAVrh74.MHCK7.micro-Dystrophin for Duchenne muscular dystrophy (DMD).
-
The Loncar Cancer Immunotherapy Index has reduced the number of immunotherapy-focused companies from 30 to 25 and also swapped out a number of stocks as part of an effort to strengthen the index’s liquidity profile and ensure the holdings hold equal weight.
-
TG Therapeutics and Novimmune SA struck a collaborative deal worth up to $185 million on the development and commercialization of a treatment for hematologic B-cell malignancies.
-
Mauna Kea Technologies Announces Positive Results from Mayo Clinic Sponsored Prospective Multi-Center Trial in Lung Transplant Patients
6/20/2018
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe-based confocal laser endomicroscopy (pCLE) platform, today announced the publication of a prospective multicenter study (ClinicalTrials.gov Identifier: NCT01033201) that demonstrates the potential of Cellvizio to aid in the diagnosis of acute cellular rejection in lung transplant patients.
-
Precision BioSciences CSO to Join Gene Therapy Session at DIA 2018
6/20/2018
Precision BioSciences CSO Derek Jantz will present and join a panel discussion during the DIA (Drug Information Association) 2018 conference.
-
The future is now: a fifth of Brits believe we’re already co-existing with robots, new survey finds
6/20/2018
A fifth of UK adults polled ahead of UK Robotics Week believe we’re already co-existing in harmony with robots in the UK, a new survey has found, while nearly a quarter believe that there is much more scope for robots to be included in everyday society.
-
LA BioMed's Research to Improve Heart Disease Screening in Newborns Given Boost from Federal Grant
6/20/2018
A researcher from LA BioMed has been awarded $688,013 in grant funding from the National Institutes of Health to improve newborn infant screening. The proposal by Rie Sakai-Bizmark, MD, PhD, MPH is entitled "Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation."
-
Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application
6/20/2018
Exactech earned the Second Place Best Clinical Podium Presentation Award for one of five new research studies presented on the company’s latest computer guidance technology at the CAOS annual meeting.
-
Troubling New Report on Hospital Infections Comes While the Centers for Medicare & Medicaid Services Considers Discontinuing Publicly Reporting Rates
6/20/2018
One out of 25 hospital patients in the U.S. contracts a healthcare-associated infection (HAI), resulting in billions of wasted dollars and an alarming 90,000 deaths annually.
-
Leading BioSciences Reports Positive Interim Results from Phase 2 Trial of LB1148 in Patients Undergoing Major Surgery
6/19/2018
Leading BioSciences today reported positive interim data from the company’s ongoing Phase 2 clinical trial of its lead drug candidate, LB1148.
-
Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
6/19/2018
Caladrius Biosciences, Inc. announces today that that the U.S. Food and Drug Administration has granted RMAT designation to the Company’s late-stage CD34+ cell therapy program.